COPD exacerbation: factors influencing hospitalization duration.

Authors

  • K. Yu. Gashynova

DOI:

https://doi.org/10.26641/2307-0404.2015.1.40309

Keywords:

COPD, exacerbation, hospitalisation

Abstract

Studying the causes of hospitalization prolongation terms in COPD exacerbation may help optimize treatment, reduce expenditures on the patient and avoid episodes relapses. The aim of the work was to determine the factors affecting the length of hospitalization due to COPD exacerbation. A retrospective analysis of medical records of inpatients hospitalized with COPD exacerbation to therapeutic department of CI "Dnipropetrovsk municipal clinical hospital N 6" of “Dnipropetrovsk regional council" during three years was done. It was found that age, height, number of comorbidities, presence of any symptoms or changes in laboratory analyses do not affect the duration of hospitalizations due to COPD exacerbations. Regardless of the frequency of hospital admissions, length of hospitalization moderately positively and reliably correlates with the disease stage (R = 0,516, p <0,001). Decrease of respiratory function indices, especially FEV1, significantly increases the length of stay in the hospital both in case of one (R = -0,457, p <0.001) or multiple hospitalization during three years (R = -0,512, p <0.001). Reduced body weight and low body mass index during hospitalization are prognostically unfavorable factors, because these parameters, though weakly, but reliably negatively correlate with the number of days spent in the hospital (R = -0,195, p = 0,028 and R = -0,246, respectively, p = 0,005). In the population of patients hospitalized due to COPD exacerbation, moderately positive reliable correlation (R = 0,392, p <0,001) between the length of hospital stay and number of hospitalizations during three years was established. The dependence of hospitalization duration in COPD exacerbations on patient’s gender requires further investigation.

Author Biography

K. Yu. Gashynova

SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»
Department of faculty therapy and endocrinology
Dzerzhinsky str., 9, Dnipropetrovsk, 49044, Ukraine

References

Mostoviy YuM, Konstantinovich-Chіcherel'o TV, Koloshko OM, Rasputіna LV. [Respiratory function tes¬ting in patients with broncho-pulmonary diseases]. Vіn¬nitsya; 2000. Russian. 2. Lapach SN, Gubenko AV, Babich PN. [Statistic methods in medical-biological investigations by means of Exel] Kiev: Morion; 2000. Russian. 3. [On approval of clinical protocols of care in the specialty "Pulmonology"]: Order №128 MoH of Ukraine (March 19, 2007). Ukrainian. 4. Rebrova ОYu. [Statistical analysis of medical data. Application of software package STATISTICA] Мos¬cow: Mediasphera; 2002. Russian. 5. FeshchenkoYuI. [New edition of Global Initiative for Chronic Obstructive Lung Diseases]. Ukraїns'kiy pul'monologіchniy zhurnal. 2012;2: 6-8. Russian. 6. Perera PN, Armstrong EP, Sherrill DL, Skrepnek GH. Acute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortality. COPD. 2012;9:131-41. 7. Baker CL, Zou KH, R JunSu. Risk assessment of readmissions following an initial COPD-related hospitalization. International Journal of COPD. 2013;8: 551-9. 8. Elixhauser A, Au D, Podulka J. Readmissions for Chronic Obstructive Pulmonary Disease, 2008. HCUP Statistical Brief # 121. September 2011. Agency for Healthcare Research and Quality, Rockville, MD. [cited 2014 Aug 15]; [about 2 p.]. Available from: http://www.hcup-us.ahrq.gov/reports/statbriefs/sb121.pdf 9. Global Initiative for Chronic Obstructive Lung Diseases (GOLD). Global strategy for diagnosis, mana¬gement, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO workshop report WHO, 2011. [cited 2014 Aug 15]; Available from: http://www.goldcopd.com/. 10. Fletcher CM, Peto R, Tinker CM, Speizer FE. Natural history of chronic bronchitis and emphysema. Oxfor: Oxford University Press; 1976. 11. Bravein AA, Lukasz K, Arvin P, et al. Prediction model for COPD readmissions: catching up, catching our breath, and improving a national problem. Journal of Community Hospital Internal Medicine Perspectives. 2012;2(1):302-4. 12. González C, Servera E, Ferris G, Blasco ML, Marína J. Risk Factors of Readmission in Acute Exa¬cerbation of Moderate-to-Severe Chronic Obstructive Pul¬monary Disease. Archivos de Bronconeumologia. 2004;40(11):502-7. 13. Brusasco V, et al. Series ATS/ERS task force: Stan¬dardisation of lung function testing. European Respi¬ratory Journal. 2005;26:319-38. 14. Brown DW, Croft JB, Greenlund KJ, Giles WH. Trends in hospitalization with chronic obstructive pul¬monary disease – United States, 1990-2005. COPD. 2010;7:59-62.

Downloads

Published

2015-03-16

How to Cite

1.
Gashynova KY. COPD exacerbation: factors influencing hospitalization duration. Med. perspekt. [Internet]. 2015Mar.16 [cited 2024Mar.29];20(1):75-81. Available from: https://journals.uran.ua/index.php/2307-0404/article/view/40309

Issue

Section

CLINICAL MEDICINE